Find a Pediatric Clinical Trial

Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

Filter by Disease

Showing 21 - 40 of 91 trials

Title	Investigator	Disease(s)
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors [Protocol 12-116]	Roberts, Stephen	Neuroblastoma Sarcomas Osteosarcoma Soft Tissue Sarcoma
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD [Protocol 09-072]	Prockop, Susan	Blood and Marrow Transplantation Transplantation
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations [Protocol 11-198]	Pratilas, Christine	Melanoma
A Phase I/IIA Study of Dabrafenib in Children with Advanced BRAF Mutation-Positive Solid Tumors [Protocol 13-016]	Pratilas, Christine	Melanoma Pediatric Brain Tumors Solid Tumors
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma [Protocol 07-147]	Perales, Miguel-Angel	Blood & Marrow Stem Cell Transplantation Sibling and Unrelated Volunteer Lymphoma Hodgkin's Disease
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders [Protocol 00-069]	Offit, Kenneth	Hereditary Cancer & Genetics Leukemia Lymphoma Hodgkin's Disease Non-Hodgkin's Lymphoma
Analysis of Blood and Salivary Samples for Genetic Studies of Familial Cancers [Protocol 93-102]	Offit, Kenneth	Hereditary Cancer & Genetics
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation [Protocol 12-086]	O'Reilly, Richard	Blood & Marrow Stem Cell Transplantation Post-Transplant
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders [Protocol 10-150]	O'Reilly, Richard	Blood and Marrow Transplantation Transplantation Hematology Hematologic Disorders
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders [Protocol 95-024]	O'Reilly, Richard	Blood & Marrow Stem Cell Transplantation Post-Transplant Blood and Marrow Transplantation Transplantation Leukemia Lymphoma
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation [Protocol 07-055]	O'Reilly, Richard	Hematology Myelodysplastic Syndrome Leukemia Myelodysplastic Syndrome
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor [Protocol 12-053]	O'Reilly, Richard	Blood & Marrow Stem Cell Transplantation Hematology Hematologic Disorders Myelodysplastic Syndrome Leukemia Acute Lymphoblastic Leukemia Acute Myelocytic Leukemia Acute Myelogenous Leukemia Chronic Myelocytic Leukemia Myelodysplastic Syndrome Lymphoma Non-Hodgkin's Lymphoma
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders [Protocol 10-050]	O'Reilly, Richard	Blood and Marrow Transplantation Transplantation Hematology Multiple Myeloma Myelodysplastic Syndrome Leukemia Chronic Myelocytic Leukemia Myelodysplastic Syndrome Lymphoma Non-Hodgkin's Lymphoma
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV [Protocol 11-130]	O'Reilly, Richard	Blood and Marrow Transplantation Transplantation Lymphoma Non-Hodgkin's Lymphoma
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma [Protocol 11-142]	Moskowitz, Alison	Lymphoma Hodgkin's Disease
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors [Protocol 09-090]	Modak, Shakeel
A Pilot Phase II Study of Targeted Radiotherapy with 131I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors [Protocol 04-148]	Modak, Shakeel	Neuroblastoma
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma [Protocol 10-015]	Modak, Shakeel	Neuroblastoma
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma [Protocol 09-011]	Modak, Shakeel	Neuroblastoma
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients [Protocol 03-123]	Meyers, Paul	Hematology Hematologic Malignancies Sarcomas

Stay Connected

Types of Cancer

Specialized Treatments

Clinical Trials & New Treatment Strategies

Follow-Up & Survivorship Care

Find a Pediatric Clinical Trial

About Us

For Adult Patients

For Pediatric Patients

For Researchers

For Healthcare Professionals

Education & Training